➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Express Scripts
Johnson and Johnson
Baxter

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Erythromycin - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for erythromycin and what is the scope of patent protection?

Erythromycin is the generic ingredient in fifty-two branded drugs marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, Arbor Pharms Llc, Barr, Mylan, Altana, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Syosset, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Dista, Bausch, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, MLV, Hi Tech Pharma, Alpharma Us Pharms, Lilly, Perrigo New York, Renaissance Pharma, Wockhardt Bio Ag, Dow Pharm, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Amneal Pharms Co, Solvay, Robins Ah, Watson Labs, Cosette, Life Labs, Amneal Pharms, Ani Pharms Inc, Par Pharm Inc, Ross Labs, Pharmacia And Upjohn, Naska, Wyeth Ayerst, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin. Twenty-seven suppliers are listed for this compound.

Drug Prices for erythromycin

See drug prices for erythromycin

Drug Sales Revenue Trends for erythromycin

See drug sales revenues for erythromycin

Recent Clinical Trials for erythromycin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yonsei UniversityN/A
Prof Dr Jan TackN/A
Woman'sPhase 4

See all erythromycin clinical trials

Pharmacology for erythromycin
Medical Subject Heading (MeSH) Categories for erythromycin

US Patents and Regulatory Information for erythromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 061743-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis ERYC erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 062546-001 Jul 25, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal Pharms ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate GRANULE;ORAL 211204-001 Nov 1, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 050010-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Arbor Pharms Llc E.E.S. 200 erythromycin ethylsuccinate SUSPENSION;ORAL 061639-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 050182-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Express Scripts
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.